甲状腺癌组织 miR-338-3p、RAB23 表达与临床病理特征及预后的关系.Published in:Progress in Modern Biomedicine, 2024, v. 24, n. 20, p. 3897, doi. 10.13241/j.cnki.pmb.2024.20.024By:曹守纪;王昭昕;王 岩;高希涛;李淑琴Publication type:Article